Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (11-20 of 372) with videos related to

Pageof 38
Sort By:
European Journal of Heart Failure|February 19, 2005
Diagnosis and assessment of the heart failure patient: the cornerstone of effective managementKenneth Dickstein
European Heart Journal|October 1, 2005
C-reactive protein in ischaemic cardiomyopathy: assessing vascular risk in heart failureKenneth Dickstein
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 4, 2010
Inpatients are sicker than outpatients; finally it's evidence-basedKenneth Dickstein
European Heart Journal|July 25, 2015
Is substantial renal dysfunction in patients with heart failure no longer a contraindication for RAS inhibition? The power of a large, high-quality registry to illuminate major clinical issuesKenneth Dickstein
European Heart Journal|July 13, 2004
Appearances can deceive: even brave hearts can failKenneth Dickstein
European Journal of Heart Failure|February 17, 2015
Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?Kenneth Dickstein
European Heart Journal|August 31, 2011
Chronic right ventricular pacing, adverse remodelling, and CRT: an ounce of prevention?Kenneth Dickstein
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Is eplerenone a cost-effective therapy for heart failure patients after myocardial infarction?Kenneth Dickstein
European Journal of Heart Failure|January 19, 2013
Cardiac resynchronization therapy in seniors: when are we too old to deserve a device that makes us feel better and improves clinical outcomes?Kenneth Dickstein
European Journal of Heart Failure|June 20, 2017
Do real world data support and extend our ability to predict reverse remodelling following cardiac resynchronization therapy based on QRS morphology and width?Torkel Steen, Kenneth Dickstein
Pageof 38

Showing results (11-20 of 372) with videos related to

Sort By:
Pageof 38
European Journal of Heart Failure|February 19, 2005
Diagnosis and assessment of the heart failure patient: the cornerstone of effective managementKenneth Dickstein
European Heart Journal|October 1, 2005
C-reactive protein in ischaemic cardiomyopathy: assessing vascular risk in heart failureKenneth Dickstein
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 4, 2010
Inpatients are sicker than outpatients; finally it's evidence-basedKenneth Dickstein
European Heart Journal|July 25, 2015
Is substantial renal dysfunction in patients with heart failure no longer a contraindication for RAS inhibition? The power of a large, high-quality registry to illuminate major clinical issuesKenneth Dickstein
European Heart Journal|July 13, 2004
Appearances can deceive: even brave hearts can failKenneth Dickstein
European Journal of Heart Failure|February 17, 2015
Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?Kenneth Dickstein
European Heart Journal|August 31, 2011
Chronic right ventricular pacing, adverse remodelling, and CRT: an ounce of prevention?Kenneth Dickstein
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Is eplerenone a cost-effective therapy for heart failure patients after myocardial infarction?Kenneth Dickstein
European Journal of Heart Failure|January 19, 2013
Cardiac resynchronization therapy in seniors: when are we too old to deserve a device that makes us feel better and improves clinical outcomes?Kenneth Dickstein
European Journal of Heart Failure|June 20, 2017
Do real world data support and extend our ability to predict reverse remodelling following cardiac resynchronization therapy based on QRS morphology and width?Torkel Steen, Kenneth Dickstein
Pageof 38